CRISPR Therapeutics AG

CRISPR Therapeutics AG

Healthcare

NASDAQ:CRSP · NASDAQ Global Market

Market Cap $5.12B Beta 1.70 P/E (TTM) -9.2
$54.09 +2.70%

+$1.43 today

52W Low $43.23High $78.48

Vol 1.94M · Avg 1.70M

EPS (TTM) -$5.92Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+18.75%

Period High

$76.78

Period Low

$44.34

Latest

$54.09

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

$11.54B

Krystal Biotech, Inc.

Krystal Biotech, Inc.

NASDAQ:KRYS

$10.35B

Cytokinetics, Incorporated

Cytokinetics, Incorporated

NASDAQ:CYTK

$9.73B

Nuvalent, Inc.

Nuvalent, Inc.

NASDAQ:NUVL

$9.08B

TG Therapeutics, Inc.

TG Therapeutics, Inc.

NASDAQ:TGTX

$8.26B

Vaxcyte, Inc.

Vaxcyte, Inc.

NASDAQ:PCVX

$7.58B

MT

Metsera, Inc.

MTSR

$7.43B

AC

Arcellx, Inc.

ACLX

$6.73B

PTC Therapeutics, Inc.

PTC Therapeutics, Inc.

NASDAQ:PTCT

$6.52B

AK

Akero Therapeutics, Inc.

AKRO

$4.50B

What is the latest CRSP filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does CRSP have?

Intrinsic Alpha currently shows 20 recent filings for CRSP.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.